TOPB1_HUMAN - dbPTM
TOPB1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TOPB1_HUMAN
UniProt AC Q92547
Protein Name DNA topoisomerase 2-binding protein 1
Gene Name TOPBP1
Organism Homo sapiens (Human).
Sequence Length 1522
Subcellular Localization Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, spindle pole. Chromosome. Detected on unpaired autosomes in meiotic prophase cells. Detected on X and Y chromosomes during later stages of prophase.
Protein Description Required for DNA replication. Plays a role in the rescue of stalled replication forks and checkpoint control. Binds double-stranded DNA breaks and nicks as well as single-stranded DNA. Recruits the SWI/SNF chromatin remodeling complex to E2F1-responsive promoters. Down-regulates E2F1 activity and inhibits E2F1-dependent apoptosis during G1/S transition and after DNA damage. Induces a large increase in the kinase activity of ATR. [PubMed: 16530042]
Protein Sequence MSRNDKEPFFVKFLKSSDNSKCFFKALESIKEFQSEEYLQIITEEEALKIKENDRSLYICDPFSGVVFDHLKKLGCRIVGPQVVIFCMHHQRCVPRAEHPVYNMVMSDVTISCTSLEKEKREEVHKYVQMMGGRVYRDLNVSVTHLIAGEVGSKKYLVAANLKKPILLPSWIKTLWEKSQEKKITRYTDINMEDFKCPIFLGCIICVTGLCGLDRKEVQQLTVKHGGQYMGQLKMNECTHLIVQEPKGQKYECAKRWNVHCVTTQWFFDSIEKGFCQDESIYKTEPRPEAKTMPNSSTPTSQINTIDSRTLSDVSNISNINASCVSESICNSLNSKLEPTLENLENLDVSAFQAPEDLLDGCRIYLCGFSGRKLDKLRRLINSGGGVRFNQLNEDVTHVIVGDYDDELKQFWNKSAHRPHVVGAKWLLECFSKGYMLSEEPYIHANYQPVEIPVSHKPESKAALLKKKNSSFSKKDFAPSEKHEQADEDLLSQYENGSSTVVEAKTSEARPFNDSTHAEPLNDSTHISLQEENQSSVSHCVPDVSTITEEGLFSQKSFLVLGFSNENESNIANIIKENAGKIMSLLSRTVADYAVVPLLGCEVEATVGEVVTNTWLVTCIDYQTLFDPKSNPLFTPVPVMTGMTPLEDCVISFSQCAGAEKESLTFLANLLGASVQEYFVRKSNAKKGMFASTHLILKERGGSKYEAAKKWNLPAVTIAWLLETARTGKRADESHFLIENSTKEERSLETEITNGINLNSDTAEHPGTRLQTHRKTVVTPLDMNRFQSKAFRAVVSQHARQVAASPAVGQPLQKEPSLHLDTPSKFLSKDKLFKPSFDVKDALAALETPGRPSQQKRKPSTPLSEVIVKNLQLALANSSRNAVALSASPQLKEAQSEKEEAPKPLHKVVVCVSKKLSKKQSELNGIAASLGADYRWSFDETVTHFIYQGRPNDTNREYKSVKERGVHIVSEHWLLDCAQECKHLPESLYPHTYNPKMSLDISAVQDGRLCNSRLLSAVSSTKDDEPDPLILEENDVDNMATNNKESAPSNGSGKNDSKGVLTQTLEMRENFQKQLQEIMSATSIVKPQGQRTSLSRSGCNSASSTPDSTRSARSGRSRVLEALRQSRQTVPDVNTEPSQNEQIIWDDPTAREERARLASNLQWPSCPTQYSELQVDIQNLEDSPFQKPLHDSEIAKQAVCDPGNIRVTEAPKHPISEELETPIKDSHLIPTPQAPSIAFPLANPPVAPHPREKIITIEETHEELKKQYIFQLSSLNPQERIDYCHLIEKLGGLVIEKQCFDPTCTHIVVGHPLRNEKYLASVAAGKWVLHRSYLEACRTAGHFVQEEDYEWGSSSILDVLTGINVQQRRLALAAMRWRKKIQQRQESGIVEGAFSGWKVILHVDQSREAGFKRLLQSGGAKVLPGHSVPLFKEATHLFSDLNKLKPDDSGVNIAEAAAQNVYCLRTEYIADYLMQESPPHVENYCLPEAISFIQNNKELGTGLSQKRKAPTEKNKIKRPRVH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Acetylation--MSRNDKEPFFVKF
--CCCCCCCCCHHHH
71.4825953088
6Ubiquitination--MSRNDKEPFFVKF
--CCCCCCCCCHHHH
71.48-
15UbiquitinationPFFVKFLKSSDNSKC
CCHHHHHCCCCCCHH
51.55-
16PhosphorylationFFVKFLKSSDNSKCF
CHHHHHCCCCCCHHH
45.1030387612
21AcetylationLKSSDNSKCFFKALE
HCCCCCCHHHHHHHH
41.1226051181
21UbiquitinationLKSSDNSKCFFKALE
HCCCCCCHHHHHHHH
41.12-
25AcetylationDNSKCFFKALESIKE
CCCHHHHHHHHHHHH
31.6325953088
31UbiquitinationFKALESIKEFQSEEY
HHHHHHHHHHCCHHH
62.85-
72AcetylationGVVFDHLKKLGCRIV
CCHHHHHHHHCCEEE
42.4025953088
72UbiquitinationGVVFDHLKKLGCRIV
CCHHHHHHHHCCEEE
42.40-
127PhosphorylationKREEVHKYVQMMGGR
HHHHHHHHHHHHCCE
4.8822817900
142PhosphorylationVYRDLNVSVTHLIAG
EECCCCEEEEEEECC
21.8920068231
144PhosphorylationRDLNVSVTHLIAGEV
CCCCEEEEEEECCCC
11.9420068231
153PhosphorylationLIAGEVGSKKYLVAA
EECCCCCCCEEEEEC
31.02-
155UbiquitinationAGEVGSKKYLVAANL
CCCCCCCEEEEECCC
45.58-
163UbiquitinationYLVAANLKKPILLPS
EEEECCCCCCCCCHH
57.20-
164UbiquitinationLVAANLKKPILLPSW
EEECCCCCCCCCHHH
40.22-
178UbiquitinationWIKTLWEKSQEKKIT
HHHHHHHHHHHHCCE
45.95-
185PhosphorylationKSQEKKITRYTDINM
HHHHHCCEECCCCCH
26.8827251275
187PhosphorylationQEKKITRYTDINMED
HHHCCEECCCCCHHH
10.5027251275
188PhosphorylationEKKITRYTDINMEDF
HHCCEECCCCCHHHC
27.4127251275
224UbiquitinationEVQQLTVKHGGQYMG
HHHHHEEECCCEEEE
31.1521890473
224UbiquitinationEVQQLTVKHGGQYMG
HHHHHEEECCCEEEE
31.1521890473
234UbiquitinationGQYMGQLKMNECTHL
CEEEEEEECCCCCEE
31.62-
247UbiquitinationHLIVQEPKGQKYECA
EEEEECCCCCCEEHH
73.54-
283AcetylationCQDESIYKTEPRPEA
CCCCCCCCCCCCCCC
44.7526051181
283UbiquitinationCQDESIYKTEPRPEA
CCCCCCCCCCCCCCC
44.75-
291UbiquitinationTEPRPEAKTMPNSST
CCCCCCCCCCCCCCC
43.63-
292PhosphorylationEPRPEAKTMPNSSTP
CCCCCCCCCCCCCCC
44.9328450419
296PhosphorylationEAKTMPNSSTPTSQI
CCCCCCCCCCCHHHH
29.7128450419
297PhosphorylationAKTMPNSSTPTSQIN
CCCCCCCCCCHHHHC
45.0828450419
298PhosphorylationKTMPNSSTPTSQINT
CCCCCCCCCHHHHCC
30.3317525332
300PhosphorylationMPNSSTPTSQINTID
CCCCCCCHHHHCCCC
33.0928450419
301PhosphorylationPNSSTPTSQINTIDS
CCCCCCHHHHCCCCC
30.2117525332
305PhosphorylationTPTSQINTIDSRTLS
CCHHHHCCCCCCCHH
27.9925850435
308PhosphorylationSQINTIDSRTLSDVS
HHHCCCCCCCHHHHH
24.2624247654
340PhosphorylationLNSKLEPTLENLENL
HHHCCHHHHHHHHCC
37.0128464451
350PhosphorylationNLENLDVSAFQAPED
HHHCCCCCCCCCCHH
24.0425159151
370PhosphorylationRIYLCGFSGRKLDKL
EEEECCCCCCHHHHH
23.9925159151
397PhosphorylationNQLNEDVTHVIVGDY
HHCCCCCEEEEECCC
23.8122210691
404PhosphorylationTHVIVGDYDDELKQF
EEEEECCCCHHHHHH
21.2622210691
414UbiquitinationELKQFWNKSAHRPHV
HHHHHHHHCCCCCCC
39.35-
471PhosphorylationLLKKKNSSFSKKDFA
HHHHCCCCCCCCCCC
42.8224719451
482AcetylationKDFAPSEKHEQADED
CCCCCCHHHHHHCHH
57.7026051181
492PhosphorylationQADEDLLSQYENGSS
HHCHHHHHHHHCCCC
37.7017525332
494PhosphorylationDEDLLSQYENGSSTV
CHHHHHHHHCCCCEE
14.1623186163
498PhosphorylationLSQYENGSSTVVEAK
HHHHHCCCCEEEEEE
34.1229523821
499PhosphorylationSQYENGSSTVVEAKT
HHHHCCCCEEEEEEC
26.9829523821
500PhosphorylationQYENGSSTVVEAKTS
HHHCCCCEEEEEECC
30.2123186163
554PhosphorylationITEEGLFSQKSFLVL
CCCCCCCCCCEEEEE
41.5622817900
581AcetylationIIKENAGKIMSLLSR
HHHHHHHHHHHHHHH
32.5919608861
584PhosphorylationENAGKIMSLLSRTVA
HHHHHHHHHHHHHHC
29.6324719451
587PhosphorylationGKIMSLLSRTVADYA
HHHHHHHHHHHCCCC
31.0624719451
618PhosphorylationVTNTWLVTCIDYQTL
CCCEEEEEEEEHHHC
11.11-
734PhosphorylationTGKRADESHFLIENS
HCCCCCHHCEEEECC
21.7828555341
741PhosphorylationSHFLIENSTKEERSL
HCEEEECCCHHHHCC
28.24-
742PhosphorylationHFLIENSTKEERSLE
CEEEECCCHHHHCCH
54.80-
743UbiquitinationFLIENSTKEERSLET
EEEECCCHHHHCCHH
58.35-
747PhosphorylationNSTKEERSLETEITN
CCCHHHHCCHHHHCC
33.5625159151
753PhosphorylationRSLETEITNGINLNS
HCCHHHHCCCCCCCC
22.5928555341
776PhosphorylationRLQTHRKTVVTPLDM
CCEECCCEEECCCCH
21.8422199227
779PhosphorylationTHRKTVVTPLDMNRF
ECCCEEECCCCHHHH
17.5025159151
788PhosphorylationLDMNRFQSKAFRAVV
CCHHHHHHHHHHHHH
24.2026074081
789UbiquitinationDMNRFQSKAFRAVVS
CHHHHHHHHHHHHHH
40.54-
805PhosphorylationHARQVAASPAVGQPL
HHHHHHCCCCCCCCC
12.0325159151
817PhosphorylationQPLQKEPSLHLDTPS
CCCCCCCCCCCCCCH
29.5229255136
822PhosphorylationEPSLHLDTPSKFLSK
CCCCCCCCCHHHCCC
35.5029255136
824PhosphorylationSLHLDTPSKFLSKDK
CCCCCCCHHHCCCCC
37.8329255136
834AcetylationLSKDKLFKPSFDVKD
CCCCCCCCCCCCHHH
50.6325953088
836PhosphorylationKDKLFKPSFDVKDAL
CCCCCCCCCCHHHHH
34.3723186163
840UbiquitinationFKPSFDVKDALAALE
CCCCCCHHHHHHHHC
38.84-
848PhosphorylationDALAALETPGRPSQQ
HHHHHHCCCCCCCCC
31.7130266825
853PhosphorylationLETPGRPSQQKRKPS
HCCCCCCCCCCCCCC
43.8330266825
856UbiquitinationPGRPSQQKRKPSTPL
CCCCCCCCCCCCCCH
55.54-
860PhosphorylationSQQKRKPSTPLSEVI
CCCCCCCCCCHHHHH
45.7725159151
861PhosphorylationQQKRKPSTPLSEVIV
CCCCCCCCCHHHHHH
36.4525159151
864PhosphorylationRKPSTPLSEVIVKNL
CCCCCCHHHHHHHHH
30.9025159151
878PhosphorylationLQLALANSSRNAVAL
HHHHHHCCCCCCHHH
25.6825159151
879PhosphorylationQLALANSSRNAVALS
HHHHHCCCCCCHHHC
29.3925159151
886PhosphorylationSRNAVALSASPQLKE
CCCCHHHCCCHHHHH
19.5730266825
888PhosphorylationNAVALSASPQLKEAQ
CCHHHCCCHHHHHHH
15.1422167270
921PhosphorylationKKLSKKQSELNGIAA
HHHCHHHHHHHHHHH
53.5922210691
998PhosphorylationHTYNPKMSLDISAVQ
CCCCCCCCEECHHHC
29.0829396449
1002PhosphorylationPKMSLDISAVQDGRL
CCCCEECHHHCCCCC
23.2725159151
1012PhosphorylationQDGRLCNSRLLSAVS
CCCCCCCHHHHHHHH
24.2518491316
1016PhosphorylationLCNSRLLSAVSSTKD
CCCHHHHHHHHCCCC
31.0825159151
1019PhosphorylationSRLLSAVSSTKDDEP
HHHHHHHHCCCCCCC
31.8228674419
1020PhosphorylationRLLSAVSSTKDDEPD
HHHHHHHCCCCCCCC
32.6426270265
1021PhosphorylationLLSAVSSTKDDEPDP
HHHHHHCCCCCCCCC
30.8726270265
1058SumoylationGSGKNDSKGVLTQTL
CCCCCCCCCHHHHHH
56.77-
1058SumoylationGSGKNDSKGVLTQTL
CCCCCCCCCHHHHHH
56.77-
1058UbiquitinationGSGKNDSKGVLTQTL
CCCCCCCCCHHHHHH
56.77-
1062PhosphorylationNDSKGVLTQTLEMRE
CCCCCHHHHHHHHHH
19.6617525332
1064PhosphorylationSKGVLTQTLEMRENF
CCCHHHHHHHHHHHH
21.3228188228
1082PhosphorylationLQEIMSATSIVKPQG
HHHHHHHHCCCCCCC
16.2228555341
1083PhosphorylationQEIMSATSIVKPQGQ
HHHHHHHCCCCCCCC
25.7128555341
1093PhosphorylationKPQGQRTSLSRSGCN
CCCCCCCCCCCCCCC
26.91-
1095PhosphorylationQGQRTSLSRSGCNSA
CCCCCCCCCCCCCCC
24.9422798277
1126PhosphorylationVLEALRQSRQTVPDV
HHHHHHHHCCCCCCC
21.6620860994
1129PhosphorylationALRQSRQTVPDVNTE
HHHHHCCCCCCCCCC
32.6623312004
1135PhosphorylationQTVPDVNTEPSQNEQ
CCCCCCCCCCCCCCC
49.4729523821
1138PhosphorylationPDVNTEPSQNEQIIW
CCCCCCCCCCCCCCC
39.1317525332
1149PhosphorylationQIIWDDPTAREERAR
CCCCCCCCHHHHHHH
45.3923312004
1159PhosphorylationEERARLASNLQWPSC
HHHHHHHHHCCCCCC
42.5419477925
1170PhosphorylationWPSCPTQYSELQVDI
CCCCCCCCEEEEEEH
13.4428122231
1171PhosphorylationPSCPTQYSELQVDIQ
CCCCCCCEEEEEEHH
23.2428122231
1183PhosphorylationDIQNLEDSPFQKPLH
EHHCCCCCCCCCCCC
20.4526074081
1192PhosphorylationFQKPLHDSEIAKQAV
CCCCCCCHHHHHHHH
21.8325159151
1216PhosphorylationEAPKHPISEELETPI
CCCCCCCCCCCCCCC
29.4822199227
1221PhosphorylationPISEELETPIKDSHL
CCCCCCCCCCCCCCC
42.8325159151
1226PhosphorylationLETPIKDSHLIPTPQ
CCCCCCCCCCCCCCC
18.3929523821
1231PhosphorylationKDSHLIPTPQAPSIA
CCCCCCCCCCCCCEE
22.5025159151
1236PhosphorylationIPTPQAPSIAFPLAN
CCCCCCCCEEEECCC
29.5729523821
1253UbiquitinationVAPHPREKIITIEET
CCCCCCHHCEEEHHH
40.46-
1256PhosphorylationHPREKIITIEETHEE
CCCHHCEEEHHHHHH
26.3023403867
1260PhosphorylationKIITIEETHEELKKQ
HCEEEHHHHHHHHHH
23.0723403867
1265UbiquitinationEETHEELKKQYIFQL
HHHHHHHHHHHHHHH
40.90-
1283PhosphorylationNPQERIDYCHLIEKL
CHHHHHHHHHHHHHH
4.5729396449
1289UbiquitinationDYCHLIEKLGGLVIE
HHHHHHHHHCCEEEE
45.50-
1297AcetylationLGGLVIEKQCFDPTC
HCCEEEEEECCCCCC
41.0426051181
1297UbiquitinationLGGLVIEKQCFDPTC
HCCEEEEEECCCCCC
41.04-
1317UbiquitinationGHPLRNEKYLASVAA
CCCCCCHHHHHHHHC
49.46-
1412MethylationQSREAGFKRLLQSGG
CCHHHHHHHHHHCCC
41.02-
1421UbiquitinationLLQSGGAKVLPGHSV
HHHCCCCEECCCCCC
47.8021890473
1421UbiquitinationLLQSGGAKVLPGHSV
HHHCCCCEECCCCCC
47.8021890473
1432UbiquitinationGHSVPLFKEATHLFS
CCCCCHHHHHHHHHH
54.87-
1439PhosphorylationKEATHLFSDLNKLKP
HHHHHHHHHHHHCCC
47.7729507054
1443UbiquitinationHLFSDLNKLKPDDSG
HHHHHHHHCCCCCCC
66.25-
1445UbiquitinationFSDLNKLKPDDSGVN
HHHHHHCCCCCCCCC
48.27-
1449PhosphorylationNKLKPDDSGVNIAEA
HHCCCCCCCCCHHHH
52.6128555341
1501PhosphorylationQNNKELGTGLSQKRK
HCCCCCCCCCCCCCC
47.8029255136
1504PhosphorylationKELGTGLSQKRKAPT
CCCCCCCCCCCCCCC
34.6929255136
1506UbiquitinationLGTGLSQKRKAPTEK
CCCCCCCCCCCCCCC
53.11-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
492SPhosphorylationKinaseATMQ13315
PSP
554SPhosphorylationKinaseATMQ13315
PSP
848TPhosphorylationKinaseCDK2P24941
PSP
853SPhosphorylationKinaseATMQ13315
PSP
1062TPhosphorylationKinaseATMQ13315
PSP
1138SPhosphorylationKinaseATMQ13315
PSP
1159SPhosphorylationKinaseAKT1P31749
PSP
-KUbiquitinationE3 ubiquitin ligaseUBR5O95071
PMID:11714696

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TOPB1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TOPB1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TOP2B_HUMANTOP2Bphysical
9461304
E2F1_HUMANE2F1physical
12697828
E2F1_HUMANE2F1physical
14576433
PML_HUMANPMLphysical
12773567
UBR5_HUMANUBR5physical
11714696
ZBT17_HUMANZBTB17physical
12408820
RAD9A_HUMANRAD9Aphysical
11395493
DPOE1_HUMANPOLEphysical
11395493
RAD9A_HUMANRAD9Aphysical
17575048
PMS2_HUMANPMS2physical
20029092
MSH6_HUMANMSH6physical
20029092
ABL1_HUMANABL1physical
15961388
FANCJ_HUMANBRIP1physical
20159562
RFA1_HUMANRPA1physical
20159562
NBN_HUMANNBNphysical
17765870
MDC1_HUMANMDC1physical
21482717
E2F1_HUMANE2F1physical
17006541
AKT1_HUMANAKT1physical
17006541
TOPB1_HUMANTOPBP1physical
17006541
ATRIP_HUMANATRIPphysical
17616665
PML_HUMANPMLphysical
19023333
VIGLN_HUMANHDLBPphysical
22939629
CHK1_HUMANCHEK1physical
17686975
DTD1_HUMANDTD1physical
20065034
CDC45_HUMANCDC45physical
20065034
TICRR_HUMANTICRRphysical
21700459
HSP7C_HUMANHSPA8physical
24239288
MDC1_HUMANMDC1physical
24239288
GRP78_HUMANHSPA5physical
24239288
ACTG_HUMANACTG1physical
24239288
BLM_HUMANBLMphysical
24239288
DDB1_HUMANDDB1physical
24239288
DCAF1_HUMANVPRBPphysical
24239288
SMC4_HUMANSMC4physical
24239288
RMI1_HUMANRMI1physical
24239288
PSF1_HUMANGINS1physical
23629628
ERCC2_HUMANERCC2physical
26344197
SMRCD_HUMANSMARCAD1physical
28063255
FANCJ_HUMANBRIP1physical
23157317
BRCA1_HUMANBRCA1physical
23157317

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TOPB1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-581, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-888, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-779; THR-848; SER-860;THR-861; SER-864; SER-888 AND SER-1002, AND MASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-805; SER-888 ANDSER-1002, AND MASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-298; SER-301; SER-492;THR-1062 AND SER-1138, AND MASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-805 AND SER-888, ANDMASS SPECTROMETRY.

TOP